NDC 70843-001-01 - Powerbooster Original
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70843-001
- Requested NDC
- 70843-001-01
- Package NDCs from labels
- 70843-001-01, 70843-001-02
- Manufacturer
- Peterpanlab | ATEC Co., Ltd.
- Effective date
- 2018-07-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Drug Facts_70843-001 Powerbooster Original | Peterpanlab | ATEC Co., Ltd. | 2018-07-26 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70843-001-02 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-5627-a910-e053-dadaa90a0b85 | Drug Facts_70843-001 Powerbooster Original |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70843-001-01 | Powerbooster Original | 100 mL in 1 TUBE | CREAM | 100 | 1 | |
| 70843-001-02 | Powerbooster Original | 1 in 1 CARTON | CREAM | 1 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | WALGREENS | 07d34e7a-c0c6-f3c4-e063-6294a90aa5c3 | 2026-10-26 | Warnings | 3G6A5W338E |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2026-10-26 | Warnings | PDC6A3C0OX |
| Maximum Strength Gas Relief | MAXIMUM STRENGTH GAS RELIEF | Famora Inc | 8ee9549d-64dd-41cd-8a4a-93e9e8f4733e | 2026-10-26 | Warnings | 92RU3N3Y1O |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2026-10-26 | Warnings | PDC6A3C0OX |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | CVS Pharmacy | 9e459853-5951-4ae7-88a6-85b502e9dd41 | 2026-10-26 | Warnings | 3G6A5W338E |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Excedrin Migraine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Select Consumer Group | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2026-10-24 | Warnings | 3G6A5W338E |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | Select Consumer Group | 3caa0a47-de83-90d2-e063-6394a90a3436 | 2026-10-24 | Warnings | 3G6A5W338E |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2026-10-23 | Warnings | PDC6A3C0OX |
| DERMASIL DRYSKIN | DIMETHICONE | Fantasia Beauty LLC | 8a49f4be-8a73-41ca-86f4-11a707b2987a | 2026-10-22 | Warnings | 92RU3N3Y1O |
| Publix Infants Dye Free Gas Relief | SIMETHICONE | PUBLIX SUPER MARKETS, INC | 2fe74800-a1f6-4774-9976-d6767ba34b49 | 2026-10-22 | Warnings | 92RU3N3Y1O |
| JET ALERT Regular Strength | CAFFEINE | Bell Pharmaceuticals, Inc | cd7366f9-6ee9-4f1d-bfd2-3ce067f59b2d | 2026-10-22 | Warnings | 3G6A5W338E |
| JET ALERT Double Strength | CAFFINE | Bell Pharmaceuticals, Inc | 9988c8cb-3fe3-40a6-beca-febd1735b171 | 2026-10-22 | Warnings | 3G6A5W338E |
| Alert Aid | CAFFEINE | Amerisource Bergen | 7f80346e-fe30-4a22-aa42-193c5fad93a2 | 2026-10-22 | Warnings | 3G6A5W338E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.